Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
486,687.00
Year-over-Year Change
7.45%
Date Range
10/1/2000 - 4/1/2025
Summary
This economic indicator tracks long-term debt for pharmaceutical and medicine corporations in the United States, specifically focusing on loans due beyond one year. The metric provides critical insights into the financial leverage and borrowing strategies of a key sector in the U.S. economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The trend represents the aggregate long-term debt obligations of pharmaceutical and medicine corporations, excluding standard debt instruments like bonds. Economists use this data to assess sector-specific financial health, investment capacity, and potential risk exposure.
Methodology
Data is collected through quarterly financial reports submitted by corporations in the pharmaceutical and medicine manufacturing sectors, compiled and standardized by federal economic research agencies.
Historical Context
This indicator is used by policymakers, investors, and financial analysts to evaluate the financial dynamics and potential investment opportunities within the pharmaceutical industry.
Key Facts
- Tracks non-standard long-term debt in pharmaceutical corporations
- Provides insights into sector-specific financial strategies
- Helps assess potential investment risks and opportunities
FAQs
Q: What does this economic indicator measure?
A: It measures long-term loans and debt obligations for U.S. pharmaceutical and medicine corporations that are due in more than one year.
Q: Why is this data important?
A: The data helps investors and analysts understand the financial health and borrowing patterns of the pharmaceutical sector.
Q: How often is this data updated?
A: The data is typically updated quarterly, providing a current snapshot of the sector's financial landscape.
Q: How can policymakers use this information?
A: Policymakers can assess sector financial trends, potential economic risks, and develop targeted economic strategies.
Q: What are the limitations of this indicator?
A: The data only covers specific types of long-term loans and does not include all forms of corporate debt or financing.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Machinery: Trade Accounts and Trade Notes Receivable (Less Allowance for Doubtful Accounts)
QFRD213333USNO
Quarterly Financial Report: U.S. Corporations: All Mining: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks
QFR301MINUSNO
Quarterly Financial Report: U.S. Corporations: Printing and Related Support Activities: Net Sales, Receipts, and Operating Revenues
QFR101323USNO
Quarterly Financial Report: U.S. Corporations: Communications Equipment: Long-Term Debt, Due in More Than 1 Year: Loans from Banks
QFR316384USNO
Quarterly Financial Report: U.S. Corporations: Management and Technical Consulting Services: Net Income Retained in Business
QFRNIRB546USNO
Quarterly Financial Report: U.S. Corporations: Food: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319311USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans [QFRD319385USNO], retrieved from FRED.
Last Checked: 8/1/2025